The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer who relapsed after S-1 adjuvant therapy, XP after TS-1 adjuvant failure (XParTS).
 
Masazumi Takahashi
Honoraria - Chugai Pharma
 
Akira Tsuburaya
No Relationships to Disclose
 
Kazuhiro Nishikawa
Honoraria - Ajinomoto; Chugai Pharma; Taiho Pharmaceutical; TERUMO; Tsumura & Co.; Yakult Pharmaceutical
Research Funding - Taiho Pharmaceutical; Yakult Pharmaceutical
 
Kazuaki Tanabe
No Relationships to Disclose
 
Kensei Yamaguchi
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Takeda
Research Funding - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Lilly; Merck Serono; Quintiles; Taiho Pharmaceutical; Yakult Honsha
 
Shigefumi Yoshino
No Relationships to Disclose
 
Tsutomu Namikawa
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - Abbott Laboratories; Chugai Pharma; Covidien; Johnson & Johnson; Kaken Pharmaceutical; Lilly; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Novartis
Research Funding - Chugai Pharma; Covidien; Daiichi Sankyo; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Yasushi Rino
No Relationships to Disclose
 
Junji Kawada
No Relationships to Disclose
 
Akihito Tsuji
No Relationships to Disclose
 
Koichi Taira
No Relationships to Disclose
 
Ryohei Kawabata
No Relationships to Disclose
 
Yasuhiro Kodera
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Pfizer; Taiho Pharmaceutical
 
Yoshinori Hirashima
No Relationships to Disclose
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Naoki Hirabayashi
No Relationships to Disclose
 
Kazumasa Fujitani
No Relationships to Disclose
 
Satoshi Morita
No Relationships to Disclose
 
Junichi Sakamoto
No Relationships to Disclose